Back to results
US 2023/0235327 A1Published application
A dbait molecule in combination with kras inhibitor for the treatment of cancer
AssigneeOnxeo
InventorsWAEL JDEY, FRANÇOISE BONO
Life of this patent
Estimating the term…
Abstract
The present invention relates to the combination of a Dbait molecule with a KRAS inhibitor for treating cancer.
Claims23
1-16. (canceled)
A pharmaceutical composition comprising a Dbait molecule and a protein KRAS inhibitor, wherein the Dbait molecule has one of the following formulae:
- wherein N is a deoxynucleotide, n is an integer from 15 to 195, the underlined N refers to a nucleotide having or not a modified phosphodiester backbone, L′ is a linker, C is the molecule facilitating endocytosis selected from a lipophilic molecule or a ligand which targets cell receptor enabling receptor mediated endocytosis, L is a linker, m and p, independently, are an integer being 0 or 1.
A combination comprising a Dbait molecule and a protein KRAS inhibitor, wherein the Dbait molecule has one of the following formulae:
- wherein N is a deoxynucleotide, n is an integer from 15 to 195, the underlined N refers to a nucleotide having or not a modified phosphodiester backbone, L′ is a linker, C is the molecule facilitating endocytosis selected from a lipophilic molecule or a ligand which targets cell receptor enabling receptor mediated endocytosis, L is a linker, m and p, independently, are an integer being 0 or 1.
Dependencies are inferred from the claim text.